FMI Research Report and Overview on Near-Patient Molec | Page 8

Near-Patient Molecular Solutions Market
testing.
Near-Patient Molecular SolutionsMarket: Regional Overview
Region wise, the global near patient molecular solution market is classified into regions namely, North
America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and Africa.
North America dominated the global market for near patient molecular solution due to good
reimbursement policies for diagnostic procedures and number of clinical studies investigating the
efficiency. After North America this market is followed by Europe due to increase demand for near
patient testing growth over. Asia Pacific region is expected to perceive a significantly faster growth over
the forecast period due to a lower availability of hi-tech central laboratory testing facilities.Increasing
number of local players providing near patient testing in countries such as China is expected to boost the
market growth in APEJ region.
Near-Patient Molecular SolutionsMarket: Key Players
Some of the key players in the market of near patient molecular solution are Abbott Laboratories, Inc.
Roche Diagnostics Limited, Siemens AG, Beckman Coulter, Inc., Becton, Dickinson and Company,
Johnson & Johnson, Alere Inc., PTS Diagnostics and Nova Biomedical. Other prominent player in near
patient molecular solution market are Bayer Healthcare, BioMerieux, Bio-Rad Laboratories, Cepheid,
Danaher Corporation.

©2015 Future Market Insights, All Rights Reserved

8